Colfax Corporation plans to split its fabrication technology and specialty medical technology businesses into two independent publicly traded companies by the first quarter of 2022. “Our intention is
IN VITRO DIAGNOSTICS Mergers & Acquisitions Opko Health Inc. Bio-Reference Laboratories Inc. Opko Health Inc. acquired publicly traded Bio-Reference Laboratories Inc. (BRLI; clinical laborator